| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.9B | $3.2B | $6.8B | $19.3B | $18.5B | $0.8B | $0.0B | $0.0B |
| Cost of Revenue | $0.9B | $1.5B | $4.7B | $5.4B | $2.6B | $0.0B | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $3.1B | $4.5B | $4.8B | $3.3B | $2.0B | $1.4B | $0.5B | $0.5B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $-3.1B | $-3.9B | $-4.2B | $9.4B | $13.3B | $-0.8B | $-0.1B | $-0.2B |
| Net Income | $-2.8B | $-3.6B | $-4.7B | $8.4B | $12.2B | $-0.7B | $-0.5B | $-0.4B |
| EPS (Basic) | $-7.26 | $-9.28 | $-12.33 | $21.26 | $30.31 | — | — | — |
| EPS (Diluted) | $-7.26 | $-9.28 | $-12.33 | $20.12 | $28.29 | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.3B | $14.1B | $18.4B | $25.9B | $24.7B | $7.3B | $1.6B | $2.0B |
| Current Assets | $6.5B | $8.1B | $10.3B | $13.4B | $16.1B | $6.3B | $1.1B | $1.6B |
| Cash & Equivalents | $2.6B | $1.9B | $2.9B | $3.2B | $6.8B | $2.6B | $0.2B | $0.7B |
| Total Liabilities | $3.7B | $3.2B | $4.6B | $6.7B | $10.5B | $4.8B | $0.4B | $0.4B |
| Current Liabilities | $2.0B | $2.2B | $3.0B | $4.9B | $9.1B | $4.4B | $0.1B | $0.2B |
| Stockholders' Equity | $8.7B | $10.9B | $13.9B | $19.1B | $14.1B | $2.6B | $1.2B | $1.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-1.9B | $-3.0B | $-3.1B | $5.0B | $13.6B | $2.0B | $-0.5B | $-0.3B |
| Investing Cash Flow | $1.9B | $1.9B | $4.2B | $-5.2B | $-8.5B | $-1.7B | $-0.0B | $-0.4B |
| Capital Expenditures | $0.2B | $1.1B | $0.7B | $0.4B | $0.3B | $0.1B | $0.0B | $0.1B |
| Financing Cash Flow | $0.6B | $0.1B | $-1.4B | $-3.4B | $-0.9B | $2.0B | $0.1B | $1.2B |